Cytori Therapeutics, Inc. (USA) (NASDAQ:CYTX)

CAPS Rating: 2 out of 5

A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions.

Recs

0
Player Avatar wayne094 (< 20) Submitted: 11/16/2011 2:24:31 PM : Outperform Start Price: $2.75 CYTX Score: -25.50

more and more horse trainers and pro sport players arre looking into stem cell its a rocket about to take off.

Featured Broker Partners


Advertisement